HIV-infection (categorized according to CD4 count and ART status), sex, age category, previous history of TB, low BMI, and baseline drug-susceptibility pattern (rifampicin mono-resistant, rifampicin resistant by Xpert MTB/RIF, MDR) were not associated with an increase risk of death or loss during treatment. Here, CD4 is linked to HIV infectious disease.